This site is not affiliated with Science News Magazine
The Science Observer Report

Supplementing with resveratrol improves blood glucose level in people with Type 2 diabetes


Researchers at Tehran University of Medical Sciences in Iran report that supplementing with resveratrol can help people with Type 2 diabetes improve their blood sugar levels. In their study, they looked at the effect of resveratrol supplementation on the blood sugar level and inflammatory markers in people with Type 2 diabetes.

  • Chronic low-grade inflammation is a characteristic of Type 2 diabetes.
  • In lab and animal studies, resveratrol has been shown to exhibit anti-inflammatory effects.
  • However, clinical trials addressing these effects in people with Type 2 diabetes are limited.
  • For the current study, the Iranian researchers hypothesized that supplementation with resveratrol might improve inflammatory markers in people with Type 2 diabetes.
  • To test their hypothesis, they conducted a randomized, double-blind, placebo-controlled clinical trial.
  • They recruited 45 individuals with Type 2 diabetes and supplemented them with either 800 milligrams (mg) per day of resveratrol or placebo capsules for eight weeks.
  • The researchers measured inflammatory markers at the start and the end of the study.
  • They found that resveratrol supplementation did not affect diabetes inflammatory markers.
  • However, they discovered that resveratrol supplementation led to significant reductions in the levels of fasting blood glucose and blood pressure.
  • These results indicate that resveratrol may not improve inflammatory markers in people with Type 2 diabetes, but may reduce their fasting blood glucose and blood pressure.

These findings, which were published in the journal Nutrition Research, suggest that an eight-week supplementation with resveratrol can help reduce levels of blood glucose and blood pressure in people with Type 2 diabetes.

To read more studies on natural diabetes treatments, visit DiabetesCure.news.

Journal Reference:
Khodabandehloo H, Seyyedebrahimi S, Esfahani EN, Razi F, Meshkani R. RESVERATROL SUPPLEMENTATION DECREASES BLOOD GLUCOSE WITHOUT CHANGING THE CIRCULATING CD14 + CD16 + MONOCYTES AND INFLAMMATORY CYTOKINES IN PATIENTS WITH TYPE 2 DIABETES: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY. Nutrition Research. June 2018; 54: 40-51. DOI: 10.1016/j.nutres.2018.03.015

Get Our Free Email Newsletter
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.
Your privacy is protected. Subscription confirmation required.


Comments
comments powered by Disqus

Get Our Free Email Newsletter
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.
Your privacy is protected. Subscription confirmation required.

RECENT NEWS & ARTICLES

Get the world's best independent media newsletter delivered straight to your inbox.
x

By continuing to browse our site you agree to our use of cookies and our Privacy Policy.